One powerful approach to the study of human biology and disease involves examination of the structure and function of specific human genes that encode well characterized products. Until recently attention focused on those genes active at high levels in specialized cells. With molecular cloning technology, a wider spectrum of human genes may be considered. We propose to study two human genes-that for the X-chromosome encoded enzyme phosphoglycerate kinase (PGK) and that for a coagulation inhibitor antithrombin III (ATIII) - in an attempt to approach important problems relating to dosage compensation of X-chromosome genes, the evolution of homologous genes within a family, and and the molecular basis of inherited disease. We will isolate by cloning and fully characterize the human X-chromosome PGK gene in preparation for detailed comparative analyses of the structure and modification of this gene in cells carrying active, inactive, and chemically reactivated X-chromosomes. Our research is founded on our conviction that molecular study of a specific X-chromosome gene whose structure is defined and whose expression can be manipulated offers the most promise for determining potential roles of DNA methylation and chromatin structure in the important and incompletely understood process of dosage compensation. In a parallel project we will isolate and chracterize the cellular gene for ATIII in an effort to distinguish existing models for evolution of a proposed """"""""superfamily"""""""" of protease inhibitors and to determine the molecular basis of ATIII deficiency associated with increased risk of thromboembolism. These latter studies will employ expression of cloned ATIII genes reintroduced into mammalian cells as an assay to identify mutant classes. Due to the moderate size of ATIII protein and its cellular gene, such """"""""functional"""""""" location of mutations, we believe, may be the most practical approach to the identification of underlying genetic lesions, and may serve as an important model for similar analysis of other disorders caused by unknown mutations in moderate-sized human genes.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD018661-03
Application #
3315762
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1983-07-01
Project End
1988-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
Dinauer, M C; Orkin, S H (1992) Chronic granulomatous disease. Annu Rev Med 43:117-24
Dinauer, M C; Pierce, E A; Erickson, R W et al. (1991) Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease. Proc Natl Acad Sci U S A 88:11231-5
Skalnik, D G; Dorfman, D M; Perkins, A S et al. (1991) Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc Natl Acad Sci U S A 88:8505-9
Skalnik, D G; Strauss, E C; Orkin, S H (1991) CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem 266:16736-44
Dinauer, M C; Pierce, E A; Bruns, G A et al. (1990) Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86:1729-37
Ezekowitz, R A; Sieff, C A; Dinauer, M C et al. (1990) Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood 76:2443-8
Dinauer, M C; Curnutte, J T; Rosen, H et al. (1989) A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. J Clin Invest 84:2012-6
Hirschhorn, R; Tzall, S; Ellenbogen, A et al. (1989) Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency. J Clin Invest 83:497-501
Newburger, P E; Ezekowitz, R A; Whitney, C et al. (1988) Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma. Proc Natl Acad Sci U S A 85:5215-9
Ezekowitz, R A; Dinauer, M C; Jaffe, H S et al. (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 319:146-51

Showing the most recent 10 out of 14 publications